Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Kaplin

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
The American Journal of Psychiatry|May 2, 2019
Explaining Naltrexone's Interference With Ketamine's Antidepressant EffectMichael Wang, Adam Kaplin
International Review of Psychiatry (Abingdon, England)|January 13, 2006
Reciprocal communication between the nervous and immune systems: crosstalk, back-talk and motivational speechesAdam Kaplin, Samantha Bartner
Cerebrum : the Dana Forum on Brain Science|September 18, 2015
New Movement in Neuroscience: A Purpose-Driven LifeAdam Kaplin, Laura Anzaldi
Nature Clinical Practice. Neurology|September 18, 2008
Kleine-Levin syndrome: a disease in its own right?Jacob Taylor, Crystal Watkins, Adam Kaplin
Cerebrum : the Dana Forum on Brain Science|March 1, 2013
Cognitive impairment in multiple sclerosis: a forgotten disability rememberedKristen Rahn, Barbara Slusher, Adam Kaplin
Drug Research|November 11, 2022
A Double-blind, Placebo-controlled, Randomized, Single Ascending, and Multiple Dose Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Dose Isomyosamine Capsules in Healthy Adult SubjectsJenna Brager, Chris Chapman, Leonard Dunn, et al.
JMIR Mental Health|May 21, 2020
An Automated Mobile Mood Tracking Technology (Mood 24/7): Validation StudyAnupama Kumar, Michael Wang, Alison Riehm, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 8, 2020
Pilot randomized active-placebo-controlled trial of low-dose ketamine for the treatment of multiple sclerosis-related fatigueKathryn C Fitzgerald, Bridget Morris, Aurash Soroosh, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 13, 2017
Neuropsychiatric syndromes of multiple sclerosisRuth Murphy, Stefani O'Donoghue, Timothy Counihan, et al.
International Psychogeriatrics|December 2, 2008
IL-6 release by LPS-stimulated peripheral blood mononuclear cells as a potential biomarker in Alzheimer's diseaseAdam Kaplin, Katherine A L Carroll, Jenn Cheng, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
The American Journal of Psychiatry|May 2, 2019
Explaining Naltrexone's Interference With Ketamine's Antidepressant EffectMichael Wang, Adam Kaplin
International Review of Psychiatry (Abingdon, England)|January 13, 2006
Reciprocal communication between the nervous and immune systems: crosstalk, back-talk and motivational speechesAdam Kaplin, Samantha Bartner
Cerebrum : the Dana Forum on Brain Science|September 18, 2015
New Movement in Neuroscience: A Purpose-Driven LifeAdam Kaplin, Laura Anzaldi
Nature Clinical Practice. Neurology|September 18, 2008
Kleine-Levin syndrome: a disease in its own right?Jacob Taylor, Crystal Watkins, Adam Kaplin
Cerebrum : the Dana Forum on Brain Science|March 1, 2013
Cognitive impairment in multiple sclerosis: a forgotten disability rememberedKristen Rahn, Barbara Slusher, Adam Kaplin
Drug Research|November 11, 2022
A Double-blind, Placebo-controlled, Randomized, Single Ascending, and Multiple Dose Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Dose Isomyosamine Capsules in Healthy Adult SubjectsJenna Brager, Chris Chapman, Leonard Dunn, et al.
JMIR Mental Health|May 21, 2020
An Automated Mobile Mood Tracking Technology (Mood 24/7): Validation StudyAnupama Kumar, Michael Wang, Alison Riehm, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 8, 2020
Pilot randomized active-placebo-controlled trial of low-dose ketamine for the treatment of multiple sclerosis-related fatigueKathryn C Fitzgerald, Bridget Morris, Aurash Soroosh, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 13, 2017
Neuropsychiatric syndromes of multiple sclerosisRuth Murphy, Stefani O'Donoghue, Timothy Counihan, et al.
International Psychogeriatrics|December 2, 2008
IL-6 release by LPS-stimulated peripheral blood mononuclear cells as a potential biomarker in Alzheimer's diseaseAdam Kaplin, Katherine A L Carroll, Jenn Cheng, et al.
Pageof 2